Skip Kelly, a managing director at J.P. Morgan, provides a broad overview of how the healthcare investment landscape is shaping up in the midst of a historic pandemic, as part of MedCity’s 2021 INVEST conference.
MedCity News publishes a series of important, powerful conversations on the business of healthcare with the help of key partners and sponsors.
Hear the latest industry news first. Sign up for our daily newsletter.
We will never sell or share your information without your consent. See our privacy policy.
More from Medical Devices – MedCity News
After raising $260M, Imperative Care looks to build portfolio of stroke-care companies
Source Node: 1858454
Time Stamp: Jul 19, 2021
Unlocking the full potential of home care and remote medical monitoring for chronic conditions [Sponsored]
Source Node: 1019212
Time Stamp: Jun 28, 2021
CEO of digital therapeutics business Freespira talks about its approach to anxiety disorders
Source Node: 1019027
Time Stamp: Jul 27, 2021
AliveCor gets FDA clearance for feature to measure QT interval
Source Node: 1857945
Time Stamp: Jul 9, 2021
Docbot CEO highlights how AI can be applied to gastrointestinal image analysis
Source Node: 873198
Time Stamp: May 24, 2021
Why Medtronic decided to move now on its $1.1B Intersect ENT deal
Source Node: 1018633
Time Stamp: Aug 12, 2021
Day 2 of INVEST Precision Medicine: Life science startup pitches, biopharma software R&D, and more
Source Node: 889286
Time Stamp: Jun 10, 2021
GRIP Molecular goes with graphene to put powerful diagnostics into patient hands
Source Node: 1121552
Time Stamp: Oct 3, 2021
Why the right-to-repair conversation needs to extend further
Source Node: 1121550
Time Stamp: Oct 5, 2021
Report: Apple Watch to add blood pressure, thermometer features
Source Node: 1866011
Time Stamp: Sep 3, 2021
Dexcom finds CGM use helps people with Type 2 diabetes stay in range
Source Node: 1121554
Time Stamp: Oct 1, 2021